Core Viewpoint - Cisco Systems (CSCO) shares have increased by approximately 1.3% since the last earnings report, underperforming the S&P 500 index [1] Group 1: Earnings Report Insights - The recent earnings report indicates that estimates for Cisco have trended upward over the past month [2] - The stock has received a Zacks Rank of 3 (Hold), suggesting an expectation of in-line returns in the upcoming months [4] Group 2: VGM Scores - Cisco has an average Growth Score of C and a Momentum Score of C, while it received a D grade for Value, placing it in the bottom 40% for that investment strategy [3] - The overall aggregate VGM Score for Cisco is D, which is significant for investors not focused on a single strategy [3]

Core Viewpoint - Nutrien's shares have increased by approximately 10.1% since the last earnings report, outperforming the S&P 500, raising questions about the sustainability of this positive trend leading up to the next earnings release [1] Estimates Movement - Estimates for Nutrien have been revised upward over the past month, indicating a positive outlook for the stock [2] VGM Scores - Nutrien currently holds a poor Growth Score of F, while its Momentum Score is rated B. The stock also received a B grade for value, placing it in the top 40% for this investment strategy. Overall, the aggregate VGM Score is D, which is relevant for investors not focused on a single strategy [3] Outlook - The upward trend in estimates and the magnitude of revisions appear promising. Nutrien has a Zacks Rank of 3 (Hold), suggesting an expectation of an in-line return from the stock in the coming months [4]

Core Viewpoint - Denali Therapeutics Inc. has seen a slight increase in share price of about 0.7% over the past month, underperforming the S&P 500, raising questions about the sustainability of this trend leading up to the next earnings release [1] Group 1: Earnings and Estimates - Estimates for Denali Therapeutics have trended upward over the past month, indicating positive revisions [2] - The stock has a Zacks Rank of 3 (Hold), suggesting an expectation of in-line returns in the coming months [4] Group 2: VGM Scores - Denali Therapeutics has a poor Growth Score of F, a Momentum Score of C, and a Value Score of F, resulting in an overall aggregate VGM Score of F, placing it in the lowest quintile for investment strategies [3] Group 3: Industry Comparison - Denali Therapeutics operates within the Zacks Medical - Biomedical and Genetics industry, where Moderna has experienced a gain of 13.3% over the past month [5] - Moderna reported revenues of $108 million for the last quarter, reflecting a year-over-year decline of 35.3%, with an EPS of -$2.52 compared to -$3.07 a year ago [5] - Moderna is projected to post a loss of $2.97 per share for the current quarter, with a year-over-year change of +10.8% and a Zacks Rank of 3 (Hold) [6]

Core Viewpoint - Norwegian Cruise Line (NCLH) shares have increased by approximately 8.2% over the past month, outperforming the S&P 500, raising questions about the sustainability of this positive trend leading up to the next earnings release [1] Estimates Movement - Estimates for Norwegian Cruise Line have trended upward over the past month, indicating positive sentiment among analysts [2] VGM Scores - Norwegian Cruise Line currently holds an average Growth Score of C, a Momentum Score of D, and a Value Score of A, placing it in the top quintile for value investment strategy. The aggregate VGM Score for the stock is B, which is relevant for investors not focused on a single strategy [3] Outlook - The upward trend in estimates suggests promising potential for Norwegian Cruise Line, which holds a Zacks Rank of 3 (Hold). An in-line return is expected from the stock in the coming months [4] Industry Performance - Norwegian Cruise Line is part of the Zacks Leisure and Recreation Services industry. Caesars Entertainment, a peer in the same industry, reported revenues of $2.79 billion for the quarter ended March 2025, reflecting a year-over-year increase of 1.9% [5]

Core Viewpoint - Newmont Corporation (NEM) has experienced a 5.5% decline in share price over the past month, underperforming the S&P 500, raising questions about its upcoming earnings release and potential for recovery [1] Group 1: Earnings and Estimates - The consensus estimate for Newmont has shifted upward by 7.73% over the past month, indicating positive revisions in earnings expectations [2] - The most recent earnings report is crucial for understanding the catalysts affecting the stock's performance [1] Group 2: VGM Scores - Newmont holds a Growth Score of B, but has a low Momentum Score of F, while achieving a Value Score of B, placing it in the second quintile for value investment strategy [3] - The aggregate VGM Score for Newmont is B, which is significant for investors not focused on a single strategy [3] Group 3: Outlook - The upward trend in estimates suggests a promising outlook for Newmont, supported by a Zacks Rank of 1 (Strong Buy), indicating expectations for above-average returns in the coming months [4]

Core Viewpoint - Valmont Industries (VMI) shares have increased by approximately 9.3% since the last earnings report, outperforming the S&P 500, but there are concerns about whether this positive trend will continue leading up to the next earnings release [1] Estimates Movement - Estimates for Valmont have trended downward over the past month, indicating a potential shift in investor sentiment [2] VGM Scores - Valmont currently holds a Growth Score of B, a Momentum Score of D, and a Value Score of B, resulting in an aggregate VGM Score of B, which is relevant for investors not focused on a single strategy [3] Outlook - The downward trend in estimates suggests a negative shift, and Valmont holds a Zacks Rank of 3 (Hold), indicating expectations for an in-line return in the coming months [4]

Core Viewpoint - Liberty Oilfield Services has seen a slight increase in share price by approximately 1.1% since the last earnings report, which is underperforming compared to the S&P 500 [1] Group 1: Earnings and Estimates - Estimates for Liberty Oilfield Services have trended upward over the past month, with a significant shift of 48.95% in the consensus estimate [2] - The most recent earnings report is crucial for understanding the key drivers affecting the company's performance [1] Group 2: VGM Scores - The company currently holds an average Growth Score of C and a Momentum Score of D, while achieving an A grade in the value category, placing it in the top quintile for this investment strategy [3] - The aggregate VGM Score for Liberty Oilfield Services is B, which is relevant for investors not focused on a single strategy [3] Group 3: Outlook - The upward trend in estimates suggests a promising outlook for Liberty Oilfield Services, with a Zacks Rank of 3 (Hold), indicating expectations for an in-line return in the coming months [4]

Core Viewpoint - U.S. Bancorp (USB) shares have increased by approximately 16.7% over the past month, outperforming the S&P 500, raising questions about the sustainability of this positive trend leading up to the next earnings release [1] Earnings Estimates - Estimates for U.S. Bancorp have trended upward over the past month, indicating a positive outlook for the stock [2][4] VGM Scores - U.S. Bancorp has a poor Growth Score of F and a Momentum Score of D, but a better Value Score of B, placing it in the second quintile for the value investment strategy. The overall VGM Score for the stock is D [3] Industry Performance - U.S. Bancorp is part of the Zacks Banks - Major Regional industry, where The Bank of New York Mellon Corporation (BK) has seen a gain of 17.1% over the past month [5] - The Bank of New York Mellon reported revenues of $4.79 billion for the last quarter, reflecting a year-over-year increase of 5.9%, with an EPS of $1.58 compared to $1.29 a year ago [6] - For the current quarter, The Bank of New York Mellon is expected to report earnings of $1.70 per share, indicating a year-over-year change of 12.6% [6] - The Bank of New York Mellon also holds a Zacks Rank 3 (Hold) and has a VGM Score of F [7]

Core Viewpoint - RH shares have increased by approximately 23.7% since the last earnings report, outperforming the S&P 500, raising questions about the sustainability of this positive trend leading up to the next earnings release [1] Estimates Movement - Estimates for RH have trended downward over the past month, with a consensus estimate shift of -9.58% [2] VGM Scores - RH has a poor Growth Score of F, a Momentum Score of C, and a Value Score of C, resulting in an overall aggregate VGM Score of F, indicating a lack of strong performance across investment strategies [3] Outlook - The downward trend in estimates suggests a negative outlook for RH, reflected in its Zacks Rank of 4 (Sell), indicating expectations of below-average returns in the coming months [4]